NPI registry status
Active
2026 NPPES data Infectious Disease Physician NPI 1891716155 MD
Verify on CMS → Imad Durra, MD
Infectious Disease Physician in Lewiston, Maine.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 8,292 in Infectious Disease Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
610
Medicare Part D claims · 103 beneficiaries · Infectious Disease Physician avg: 816
Generic prescribing
65%
generic claims · 35% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
84/100
▲ 1 pts above national avg 83.1 · Above neutral
Industry payments
$17.77
1 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Imad Durra, MD reported a CMS MIPS final score of 84/100 - above the 83.1 national average - and filed 610 Medicare Part D claims in 2023.
- 84/100
- MIPS score · +1 vs avg
- 610
- Part D claims, 2023
- 65%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Imad Durra, MD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
84 42nd percentile higher than 42% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Imad Durra, MD sits
This provider among infectious disease physician peers
Across the 2,276 infectious disease physician providers who report both Medicare Part D prescribing and a MIPS quality score, Imad Durra, MD writes more Part D claims than 66% of them and scores higher on MIPS quality than 48% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one infectious disease physician peer from a representative sample of 60; the gold marker is Imad Durra, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Imad Durra, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 2 hospital affiliations - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Imad Durra, MD?
Near national averagePrimary specialty
Infectious Disease Physician
Medicare Part D claims
610 25% vs specialty avg
MIPS final score
84/100 0.9 pts vs avg
Specialty distribution in Maine
How Infectious Disease Physician compares to other specialties among Maine providers
Medicare quality performance, MIPS
Imad Durra, MD's 2023 MIPS final score plotted against the Infectious Disease Physician national average
- MIPS Final Score
- 84/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Infectious Disease Physician) - 84/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Imad Durra, MD appears in the CMS NPPES registry as a Infectious Disease Physician provider holding MD credentials at 76 HIGH ST, Lewiston, ME, 04240, with a listed phone of (207) 795-2729. NPI 1891716155 was issued on 07/22/2006.
Medicare Part D records for calendar year 2023 show 610 prescription claims written by this provider, covering 103 Medicare beneficiaries and totaling roughly $1.0 million in drug spend, split 35% brand-name and 65% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 84/100 for the 2023 performance year (Quality 60.7, Cost 70.8), compared with the national average of 83.1.
Infectious Disease Physician is a mid-sized specialty nationwide, with 8,292 enrolled providers across 54 states and an average of 816 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1891716155 |
|---|---|
| Specialty | Infectious Disease Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 07/22/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
83.9526
Final Score
Avg: 83.1
60.6933
Quality
70.8152
Cost
98
Promoting Interoperability
Reporting: Group practice
Hospital and facility affiliations
Facilities where Imad Durra, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Central Maine Medical Center
★★★★☆ 4/5
Lewiston, ME
Acute Care Hospitals
CMS CCN: 200024
St Marys Regional Medical Center
Lewiston, ME
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Imad Durra, MD. Source: openpaymentsdata.cms.gov.
Total received
$18
Largest payer
Merck Sharp & Dohme LLC
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Above average
Imad Durra, MD - brand share 35.0%
Infectious Disease Physician average
35% brand-name claims vs 65% generic, on 610 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
610
Total Claims
$1.0M
Total Drug Cost
103
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 670
- Total Day Supply
- 16,481
- Brand vs Generic
- 35% brand / 65% generic
- Brand Drug Cost
- $990K
- Generic Drug Cost
- $46K
- Antibiotic Claims
- 275
Patient Demographics
- Average Patient Age
- 63.3 years
- Avg HCC Risk Score
- 2.65
- Gender Split
- 36% female / 64% male
- Age Distribution
- <65: 45, 65-74: 44, 75-84: N/A, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Imad Durra, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Tivicay
Tivicay
43 claims
- Ampicillin-Sulbactam
Ampicillin-Sulbactam
36 claims
- Biktarvy
Biktarvy
33 claims
- Azithromycin
Azithromycin
30 claims
- Descovy
Descovy
30 claims
- Ethambutol Hcl
Ethambutol Hcl
30 claims
- Emtricitabine-Teno…
Emtricitabine-Tenofovir Disop
25 claims
- Doxycycline Monohy…
Doxycycline Monohydrate
21 claims
| Drug | Claims |
|---|---|
| Tivicay Dolutegravir Sodium | 43 |
| Ampicillin-Sulbactam Ampicillin Sod/Sulbactam Sod | 36 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 33 |
| Azithromycin | 30 |
| Descovy Emtricitabine/Tenofov Alafenam | 30 |
| Ethambutol Hcl | 30 |
| Emtricitabine-Tenofovir Disop Emtricitabine/Tenofovir (Tdf) | 25 |
| Doxycycline Monohydrate | 21 |
| Amoxicillin | 20 |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 20 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Infectious Disease Physician Overview
How Imad Durra, MD fits within the Infectious Disease Physician landscape nationally.
8,292
Infectious Disease Physician Providers in US
54
States with Infectious Disease Physician
816
Avg Claims per Provider
Imad Durra, MD's 610 claims are below the specialty average of 816.
Nearby Infectious Disease Physician Providers in Maine
Other clinicians with the same primary specialty enrolled in Maine, drawn from the same CMS NPPES roster as Durra.
Dr. Leyla Azis
MD
South Portland, ME
Dr. Thomas Courtney
M.D.
Biddeford, ME
Dr. Mohamedazhar Gangat
M.D.
Bangor, ME
Dr. Rebekah Gass
M.D.
Bangor, ME
Dr. Peter Gonnella
M.D.
Rockport, ME
Compare Infectious Disease Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Maine medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Infectious Disease Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Maine
Frequently Asked Questions
What is Imad Durra, MD's specialty? ▼
Imad Durra, MD specializes in Infectious Disease Physician and practices in Lewiston, Maine. Credentials: MD.
How much does Imad Durra, MD prescribe under Medicare Part D? ▼
In 2023, Imad Durra, MD wrote 610 Medicare Part D claims totaling $1.0M in drug costs for 103 beneficiaries.
What is Imad Durra, MD's Medicare quality score? ▼
Imad Durra, MD has a CMS MIPS Final Score of 84/100 (Quality: 60.7, Cost: 70.8). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Imad Durra, MD located? ▼
Imad Durra, MD is located at 76 HIGH ST, Lewiston, ME, 04240. Phone: (207) 795-2729.
What is Imad Durra, MD's NPI number? ▼
Imad Durra, MD's National Provider Identifier (NPI) is 1891716155, issued on 07/22/2006.
Does Imad Durra, MD prescribe more brand-name or generic drugs? ▼
Imad Durra, MD's prescribing is 35% brand-name and 65% generic drugs by claim count, with $990K in brand drug costs.
How many Infectious Disease Physician providers are there in the US? ▼
There are 8,292 Infectious Disease Physician providers across 54 states in the US. The average Infectious Disease Physician provider writes 816 Medicare Part D claims per year.
What drugs does Imad Durra, MD prescribe most often? ▼
Based on 2023 Medicare Part D data, Imad Durra, MD's most frequently prescribed drugs include Tivicay, Ampicillin-Sulbactam, Biktarvy. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Imad Durra, MD accept Medicare? ▼
Imad Durra, MD appears in CMS Medicare data with 610 Part D claims and 103 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Imad Durra, MD's credentials? ▼
Imad Durra, MD's NPI is 1891716155 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.